Download PDF
Horm Metab Res 2011; 43(2): 130-134
DOI: 10.1055/s-0030-1267997
Humans, Clinical

© Georg Thieme Verlag KG Stuttgart · New York

T3/rT3-Ratio is Associated with Insulin Resistance Independent of TSH

S. Ruhla1 , 2 , A. M. Arafat1 , 2 , M. O. Weickert2 , 3 , M. Osterhoff1 , 2 , F. Isken1 , 2 , * , J. Spranger1 , 2 , C. Schöfl1 , 4 , A. F. H. Pfeiffer1 , 2 , M. Möhlig1 , 2
  • 1Department of Endocrinology, Diabetes and Nutrition, Charité-University Medicine Berlin, Campus Benjamin Franklin, Berlin, Germany
  • 2Department of Clinical Nutrition, German Institute of Human Nutrition Potsdam-Rehbruecke, Nuthetal, Germany
  • 3Warwickshire Institute for the Study of Diabetes, Endocrinology, and Metabolism, University Hospitals Coventry and Warwickshire, Coventry, United Kingdom
  • 4Division of Endocrinology and Diabetes, Department of Medicine I, Friedrich-Alexander-University Erlangen-Nuremberg, Erlangen, Germany
  • *Deceased
Further Information

Publication History

received 29.06.2010

accepted 20.10.2010

Publication Date:
22 November 2010 (online)

Also available at
    Permissions and Reprints

Abstract

Thyroid dysfunction has been shown to be associated with insulin resistance (IR). This may involve peripheral thyroid hormone metabolism, which is assumed to be reflected by the ratio triiodothyronine/reverse triiodothyronine (T3/rT3-ratio). To explore a potential association between the T3/rT3-ratio and IR we investigated pairs which differed in IR, but were matched by sex, age, body mass index (BMI), and thyroid stimulating hormone (TSH). For this purpose, matched pair analyses were embedded into a cross sectional study group. 22 pairs were matched from either the first or the third tertile of HOMA%S of a cohort of 353 euthyroid subjects with normal glucose metabolism who did not take any medication. The T3/rT3-ratio was compared in the matched pairs. The T3/rT3-ratio was significantly increased in the insulin resistant subjects compared to their insulin sensitive partners (8.78±0.47 vs. 7.33±0.33, p=0.019). Furthermore the T3/rT3-ratio was lower in men compared to women (p for the within-subject effect=0.046) both in the insulin sensitive and the insulin resistant subjects. Here we show that the T3/rT3-ratio, which is supposed to reflect the tissue thyroid hormone metabolism, is significantly increased in insulin resistant subjects. This further supports a link between thyroid function and IR.

Key words

diabetes mellitus type 2 - insulin resistance - thyroid function

References

  • 1 Ronnemaa T, Laakso M, Pyorala K, Kallio V, Puukka P. High fasting plasma insulin is an indicator of coronary heart disease in non-insulin-dependent diabetic patients and nondiabetic subjects.  Arterioscler Thromb. 1991;  11 80-90
    Google Scholar
  • 2 Skarfors ET, Selinus KI, Lithell HO. Risk factors for developing non-insulin dependent diabetes: a 10 year follow up of men in Uppsala.  BMJ. 1991;  303 755-760
    Google Scholar
  • 3 Zimmet P, Dowse G, Bennett P. Hyperinsulinaemia is a predictor of non-insulin-dependent diabetes mellitus.  Diabetes Metab. 1991;  17 101-108
    Google Scholar
  • 4 Faggiano A, Pivonello R, Spiezia S, De Martino MC, Filippella M, Di Somma C, Lombardi G, Colao A. Cardiovascular risk factors and common carotid artery caliber and stiffness in patients with Cushing's disease during active disease and 1 year after disease remission.  J Clin Endocrinol Metab. 2003;  88 2527-2533
    Google Scholar
  • 5 Seidell JC, Bjorntorp P, Sjostrom L, Kvist H, Sannerstedt R. Visceral fat accumulation in men is positively associated with insulin, glucose, and C-peptide levels, but negatively with testosterone levels.  Metabolism. 1990;  39 897-901
    Google Scholar
  • 6 Simon D, Charles MA, Nahoul K, Orssaud G, Kremski J, Hully V, Joubert E, Papoz L, Eschwege E. Association between plasma total testosterone and cardiovascular risk factors in healthy adult men: The Telecom Study.  J Clin Endocrinol Metab. 1997;  82 682-685
    Google Scholar
  • 7 Ohguni S, Notsu K, Kato Y. Correlation of plasma free thyroxine levels with insulin sensitivity and metabolic clearance rate of insulin in patients with hyperthyroid Graves’ disease.  Intern Med. 1995;  34 339-341
    Google Scholar
  • 8 Cavallo-Perin P, Bruno A, Boine L, Cassader M, Lenti G, Pagano G. Insulin resistance in Graves’ disease: a quantitative in-vivo evaluation.  Eur J Clin Invest. 1988;  18 607-613
    Google Scholar
  • 9 Dimitriadis G, Baker B, Marsh H, Mandarino L, Rizza R, Bergman R, Haymond M, Gerich J. Effect of thyroid hormone excess on action, secretion, and metabolism of insulin in humans.  Am J Physiol. 1985;  248 E593-E601
    Google Scholar
  • 10 Tene C, Zarate A, Basurto L, Islas S, Revilla C, Ochoa R, Galvan R, Santos P. Correction of insulin resistance in methimazole-treated patients with Graves disease.  Rev Invest Clin. 2001;  53 531-535
    Google Scholar
  • 11 Yavuz DG, Yuksel M, Deyneli O, Ozen Y, Aydin H, Akalin S. Association of serum paraoxonase activity with insulin sensitivity and oxidative stress in hyperthyroid and TSH-suppressed nodular goitre patients.  Clin Endocrinol (Oxf). 2004;  61 515-521
    Google Scholar
  • 12 Heemstra KA, Smit JW, Eustatia-Rutten CF, Heijboer AC, Frolich M, Romijn JA, Corssmit EP. Glucose tolerance and lipid profile in longterm exogenous subclinical hyperthyroidism and the effects of restoration of euthyroidism, a randomised controlled trial.  Clin Endocrinol (Oxf). 2006;  65 737-744
    Google Scholar
  • 13 Rochon C, Tauveron I, Dejax C, Benoit P, Capitan P, Fabricio A, Berry C, Champredon C, Thieblot P, Grizard J. Response of glucose disposal to hyperinsulinaemia in human hypothyroidism and hyperthyroidism.  Clin Sci (Lond). 2003;  104 7-15
    Google Scholar
  • 14 Stanicka S, Vondra K, Pelikanova T, Vlcek P, Hill M, Zamrazil V. Insulin sensitivity and counter-regulatory hormones in hypothyroidism and during thyroid hormone replacement therapy.  Clin Chem Lab Med. 2005;  43 715-720
    Google Scholar
  • 15 Owecki M, Nikisch E, Sowinski J. Hypothyroidism has no impact on insulin sensitivity assessed with HOMA-IR in totally thyroidectomized patients.  Acta Clin Belg. 2006;  61 69-73
    Google Scholar
  • 16 Harris PE, Walker M, Clark F, Home PD, Alberti KG. Forearm muscle metabolism in primary hypothyroidism.  Eur J Clin Invest. 1993;  23 585-588
    Google Scholar
  • 17 Jackson IM, Prentice CR, McKiddie MT. The effect of hypothyroidism on glucose tolerance and insulin metabolism.  J Endocrinol. 1970;  47 257-258
    Google Scholar
  • 18 Roos A, Bakker SJ, Links TP, Gans RO, Wolffenbuttel BH. Thyroid function is associated with components of the metabolic syndrome in euthyroid subjects.  J Clin Endocrinol Metab. 2007;  92 491-496
    Google Scholar
  • 19 Fernandez-Real JM, Lopez-Bermejo A, Castro A, Casamitjana R, Ricart W. Thyroid function is intrinsically linked to insulin sensitivity and endothelium-dependent vasodilation in healthy euthyroid subjects.  J Clin Endocrinol Metab. 2006;  91 3337-3343
    Google Scholar
  • 20 Park HT, Cho GJ, Ahn KH, Shin JH, Hong SC, Kim T, Hur JY, Kim YT, Lee KW, Kim SH. Thyroid stimulating hormone is associated with metabolic syndrome in euthyroid postmenopausal women.  Maturitas. 2009;  62 301-305
    Google Scholar
  • 21 Ruhla S, Weickert MO, Arafat AM, Osterhoff M, Isken F, Spranger J, Schöfl C, Pfeiffer AF, Möhlig M. A high normal TSH is associated with the metabolic syndrome.  Clin Endocrinol (Oxf). 2010;  72 696-701
    Google Scholar
  • 22 Mueller A, Schöfl C, Dittrich R, Cupisti S, Oppelt PG, Schild RL, Beckmann MW, Haberle L. Thyroid-stimulating hormone is associated with insulin resistance independently of body mass index and age in women with polycystic ovary syndrome.  Hum Reprod. 2009;  24 2924-2930
    Google Scholar
  • 23 Bakker SJ, ter Maaten JC, Popp-Snijders C, Slaets JP, Heine RJ, Gans RO. The relationship between thyrotropin and low density lipoprotein cholesterol is modified by insulin sensitivity in healthy euthyroid subjects.  J Clin Endocrinol Metab. 2001;  86 1206-1211
    Google Scholar
  • 24 Ortega E, Koska J, Pannacciulli N, Bunt JC, Krakoff J. Free triiodothyronine plasma concentrations are positively associated with insulin secretion in euthyroid individuals.  Eur J Endocrinol. 2008;  158 217-221
    Google Scholar
  • 25 Köhrle J. Thyroid hormone transporters in health and disease: advances in thyroid hormone deiodination.  Best Pract Res Clin Endocrinol Metab. 2007;  21 173-191
    Google Scholar
  • 26 Gereben B, Zavacki AM, Ribich S, Kim BW, Huang SA, Simonides WS, Zeold A, Bianco AC. Cellular and molecular basis of deiodinase-regulated thyroid hormone signaling.  Endocr Rev. 2008;  29 898-938
    Google Scholar
  • 27 Peeters RP, van der Deure WM, Visser TJ. Genetic variation in thyroid hormone pathway genes; polymorphisms in the TSH receptor and the iodothyronine deiodinases.  Eur J Endocrinol. 2006;  155 655-662
    Google Scholar
  • 28 Matthaei S, Stumvoll M, Kellerer M, Häring HU. Pathophysiology and pharmacological treatment of insulin resistance.  Endocr Rev. 2000;  21 585-618
    Google Scholar
  • 29 Fischer A, Fisher E, Möhlig M, Schulze M, Hoffmann K, Weickert MO, Schueler R, Osterhoff M, Pfeiffer AF, Boeing H, Spranger J. KCNJ11 E23K affects diabetes risk and is associated with the disposition index: results of two independent German cohorts.  Diabetes Care. 2008;  31 87-89
    Google Scholar
  • 30 Marassi MP, Fortunato RS, da Silva AC, Pereira VS, Carvalho DP, Rosenthal D, da Costa VM. Sexual dimorphism in thyroid function and type 1 iodothyronine deiodinase activity in pre-pubertal and adult rats.  J Endocrinol. 2007;  192 121-130
    Google Scholar
  • 31 Lisboa PC, Cabanelas AP, Curty FH, Oliveira KJ, Ortiga-Carvalho TM, Moura EG, Nascimento-Saba CC, Rosenthal D, Pazos-Moura CC. Modulation of type 2 iodothyronine deiodinase activity in rat thyroid gland.  Horm Metab Res. 2007;  39 538-541
    Google Scholar
  • 32 Fisher DA. Physiological variations in thyroid hormones: physiological and pathophysiological considerations.  Clinical Chemistry. 1996;  42 135-139
    Google Scholar
  • 33 Köhrle J. Thyroid hormone metabolism and action.  Z Arztl Fortbild Qualitatssich. 2004;  98 (S 05) 17-24
    Google Scholar
  • 34 Chidakel A, Mentuccia D, Celi FS. Peripheral metabolism of thyroid hormone and glucose homeostasis.  Thyroid. 2005;  15 899-903
    Google Scholar
  • 35 Shimizu Y, Shimazu T. Thyroid hormone augments GLUT4 expression and insulin-sensitive glucose transport system in differentiating rat brown adipocytes in culture.  J Vet Med Sci. 2002;  64 677-681
    Google Scholar
  • 36 Torrance CJ, Devente JE, Jones JP, Dohm GL. Effects of thyroid hormone on GLUT4 glucose transporter gene expression and NIDDM in rats.  Endocrinology. 1997;  138 1204-1214
    Google Scholar
  • 37 Silva JE, Larsen PR. Hormonal regulation of iodothyronine 5′-deiodinase in rat brown adipose tissue.  American Journal of Physiology. 1986;  251 E639-E643
    Google Scholar
  • 38 Mills I, Barge RM, Silva JE, Larsen PR. Insulin stimulation of iodothyronine 5′-deiodinase in rat brown adipocytes.  Biochem Biophys Res Commun. 1987;  143 81-86
    Google Scholar
  • 39 Heemstra KA, Soeters MR, Fliers E, Serlie MJ, Burggraaf J, van Doorn MB, van der Klaauw AA, Romijn JA, Smit JW, Corssmit EP, Visser TJ. Type 2 iodothyronine deiodinase in skeletal muscle: effects of hypothyroidism and fasting.  J Clin Endocrinol Metab. 2009;  94 2144-2150
    Google Scholar
  • 40 Sato K, Robbins J. Thyroid hormone metabolism in primary cultured rat hepatocytes. Effects of glucose, glucagon, and insulin.  J Clin Invest. 1981;  68 475-483
    Google Scholar
  • 41 Wacholder S, Silverman DT, McLaughlin JK, Mandel JS. Selection of controls in case-control studies. III. Design options.  Am J Epidemiol. 1992;  135 1042-1050
    Google Scholar
  • 42 Wallace TM, Levy JC, Matthews DR. Use and abuse of HOMA modeling.  Diabetes Care. 2004;  27 1487-1495
    Google Scholar

Correspondence

M. MöhligMD 

Department of Endocrinology

Diabetes and Nutrition

Charité-University Medicine

Berlin

Campus Benjamin Franklin

Hindenburgdamm 30

12200 Berlin

Germany

Phone: +49/30/8445 2114

Fax: +49/30/8445 4204

Email: matthias.moehlig@charite.de